Page Views: 255 Date Added: 05/18/2011 Last Updated: 05/18/2011 Expiry Date: 05/15/2021 Product/Service Details ACTEMRA ® (tocilizumab) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies. ACTEMRA ® (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor indicated for treatment of: Rheumatoid Arthritis ( 1 ) Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.

Company Information (3S Corporation)

Company Profile: 3s Corporation is a bulk dealer and wholesaler for oncology products and anti-cancer drugs and injections from India. We supply large quantities of drugs and medications to major markets like UK, Europe, America and Africa.. >> More Website URL: http://www.bridgat.com/u37137